富祥药业：拟由陆茜提前回购公司持有的上海凌凯3.4761%股份

Core Viewpoint - Fuxiang Pharmaceutical (300497.SZ) has agreed to sell its 3.4761% stake in Shanghai Lingkai back to Ms. Lu Qian for a total consideration of 153.67 million yuan to reduce investment risks and enhance asset operational efficiency [1] Group 1 - The company aims to focus on its core business development by divesting its stake in Shanghai Lingkai [1] - The board of directors approved the share buyback agreement during the fifth meeting of the fifth session on January 9, 2026 [1] - The management is authorized to handle the specifics of the share transfer, including signing relevant agreements [1]